97. Ulcerative colitis Clinical trials / Disease details


Clinical trials : 2,527 Drugs : 1,465 - (DrugBank : 259) / Drug target genes : 144 - Drug target pathways : 202

  
2 trials found
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries
1NCT03494764
(ClinicalTrials.gov)
September 7, 20174/4/2018Hyperbaric Oxygen Therapy for Ulcerative Colitis FlaresHyperbaric Oxygen Therapy for Moderate to Severe Ulcerative Colitis Flares: A Multi-Center Randomized TrialColitis, UlcerativeOther: Hyperbaric Oxygen TherapyDartmouth-Hitchcock Medical CenterFoundation for Clinical Research in IBD;The Eli and Edythe Broad Foundation;University of California, San Diego;Mayo Clinic;University of Pittsburgh Medical Center;Virginia Mason Memorial Hospital;University of Texas Southwestern Medical Center;University of Maryland, College Park;NYU Langone HealthCompleted18 YearsN/AAll39Phase 2United States
2NCT02144350
(ClinicalTrials.gov)
August 201313/5/2014Hyperbaric Oxygen for Ulcerative ColitisHyperbaric Oxygen Therapy for Moderate to Severe Ulcerative Colitis Flares: A Multi-center Randomized Double Blind Sham Controlled TrialUlcerative ColitisProcedure: Hyperbaric oxygen;Procedure: Sham Hyperbaric AirDartmouth-Hitchcock Medical CenterMayo Clinic;University of PittsburghTerminated18 YearsN/AAll18Phase 2/Phase 3United States